A-Biotech (Hong Kong) Company Limited

A-Biotech (Hong Kong) Company Limited is rated 3 out of 5 in the category biotechnology. Read and write reviews about A-Biotech (Hong Kong) Company Limited. A-Biotech (Hong Kong) Company Limited is the first Genome Editing Therapeutic Company in Hong Kong. The company was founded in 2017 by local scientists from The Chinese University of Hong Kong specialized in biomedical sciences, under the TSSSU scheme supported by Innovation and Technology Commission (ITC). We specialized in the research, development and commercialization of genome-editing therapeutic products. We proudly provide solutions that improve R&D quality in bio-medicine and healthcare. With our newly patented CRISPR reagent products - "KI-Brilliant"​, we help our clients to overcome difficulties and facilitate their work in biomedical research, industrial biotechnology development and therapeutic applications. Meanwhile, we are also developing one-off gene therapeutic drug for rare disease patients.